“Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway” (2025) Nigerian Journal of Physiological Sciences, 40(2), pp. 251–262. doi:10.54548/.